MarketCapTrends
LXRX
Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ · Healthcare

Lexicon Pharmaceuticals, Inc. Shareholder Equity 2009–2025

Total AssetsCash on HandLong Term DebtTotal LiabilitiesShareholder Equity

Lexicon Pharmaceuticals, Inc. annual/quarterly shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Lexicon Pharmaceuticals, Inc. shareholder equity for the quarter ending December 31, 2025 were 107.5M, a 26.32% decrease year-over-year.
  • Lexicon Pharmaceuticals, Inc. shareholder equity for 2025 were 107.5M, a 26.32% decrease from 2024.
  • Lexicon Pharmaceuticals, Inc. shareholder equity for 2024 were 145.9M, a 56.75% increase from 2023.
  • Lexicon Pharmaceuticals, Inc. shareholder equity for 2023 were 93.1M, a 20.50% decrease from 2022.
  • Lexicon Pharmaceuticals, Inc. shareholder equity for 2022 were 117.1M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Lexicon Pharmaceuticals, Inc. Annual Shareholder Equity (Millions of US $)
2025$108
2024$146
2023$93
2022$117
2021$114
2020$156
2019$117
2018$-26
2017$68
2016$168
2015$286
2014$284
2013$170
2012$267
2011$298
Lexicon Pharmaceuticals, Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$108
2024-12-31$146
2023-12-31$93
2022-12-31$117
2021-12-31$114
2020-12-31$156
2019-12-31$117
2018-12-31$-26
2017-12-31$68
2016-12-31$168
2015-12-31$286
2014-12-31$284
2013-12-31$170
2012-12-31$267
2011-12-31$298
2010-12-31$247

Lexicon Pharmaceuticals, Inc. Shareholder Equity — FAQ

Lexicon Pharmaceuticals, Inc. (LXRX) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see LXRX's shareholder equity history?

The chart and table above show Lexicon Pharmaceuticals, Inc.'s shareholder equity by year and by quarter, including the growth rate.